multi- products fuel pipeline expansion project to the northern of Thailand (phase 1 or NFPT-phase1) . The Gross profit margin of the Group was of 54.1% compared to 59.0% of Q3/2018. While in the nine

expansion project to the northern of Thailand (phase 1 or NFPT-phase1) which is recognized in this quarter. The Gross profit margin of the Group was of 47.7% compared to 54.5% of Q2/2018. While in the first

main strategies are namely, invasion of the housing market, expansion of service income, financial liquidity management and adding value to existing assets. As for the performance in Q1/2021, the net

cost saving measures to minimize the negative impact of the COVID-19 pandemic on the Company’s future operations and is hopeful that appropriate measures will also be taken by the Government to support

7,698 mn, up by 5.2% YoY with a 6% YoY growth in net profit to THB 2,483 mn. Establishment of a Joint Venture to support business expansion plan On 5 September 2017, the Company established a new joint

unit in a government hospital to provide hemodialysis services (The nd branch) that still has focused on continuous expansion of dialysis unit. On the past 29th September, 2017 the subsidiary

focused on continuous expansion of dialysis unit. On the past 29 th September, 2017 the subsidiary additionally purchased assets from business of a dialysis unit which is business expansion as a plan laid

administrative expense to support business expansion. Without the non-recurring profit related to sale of Dusit Princess Korat, core EBITDA was THB 806 million, a 12.3% decrease from 2016. The Company reported net

slower rate in March and reached its bottom in April (-8.1% YoY), it made a v-shape recovery with 18.0% growth in June, partly driven by additional supply of C-Vitt from capacity expansion. - While Q2’20

network expansion led to increasing cost of service 3.9%YoY and 3.4%QoQ; however, SG&A was well-managed and dropped -12%YoY and -8.8%QoQ, resulted in stabilized EBITDA with -0.9%YoY and +1.6%QoQ. Net profit